Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales

COPD

… chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. Dupixent is the first biologic medicine approved in the US to treat …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave